logo
Prescribing Information
Adverse Event Reporting
Search

Main navigation

  • What is Hyperkalaemia?
  • HK Challenge in CKD
  • HK Challenge in HF
  • About Veltassa
  • Clinical Experience
  • Resources
Search

Veltassa®

Terms of use

Report adverse events:

Adverse events should be reported to the Vifor Pharma group.
safety@viforpharma.com

Send email
Terms of use

Terms of Use for HCP websites
(including product references)

PLEASE READ AND REVIEW THE FOLLOWING TERMS AND CONDITIONS OF USE CAREFULLY BEFORE USING THIS WEB SITE.

General.

Welcome to Veltassa.com (the "Website"). This Website is owned by Vifor Fresenius Medical Care Renal Pharma Ltd., with registered offices at Flughofstrasse 61, CH-8152 Glattbrugg, Switzerland ("Vifor Fresenius Medical Care Renal Pharma Ltd."). This Website is hosted in Germany and is governed by Swiss law without respect to its conflict of laws principles. Your access and use of the information contained herein is subject to the following terms and conditions of use and all applicable laws.

By accessing and browsing this Website, you accept, without limitation or qualification, these terms and conditions of use and acknowledge that (i) they constitute the entire agreement between you and Vifor Fresenius Medical Care Renal Pharma Ltd. with respect to the use of this Website and (ii) they supersede any other agreement between you and Vifor Fresenius Medical Care Renal Pharma Ltd.. You agree to indemnify Vifor Fresenius Medical Care Renal Pharma Ltd. for any claims or damages resulting from your failure to abide by these terms and conditions. If you do not agree to all of these Terms and Conditions of Use, please leave the Website.

The information on this Website was developed by Vifor Fresenius Medical Care Renal Pharma Ltd. as a resource for healthcare professionals (“HCPs”). The Website is not intended for use by US HCPs. If you are not a healthcare professional, please refrain from using this site. 

Some information on this Website may relate to medical, health or fitness conditions, their prevention and treatment. Any references to products or services on the Website do not imply that Vifor Fresenius Medical Care Renal Pharma Ltd. offers or intends to offer these products or services in your country. Please always refer to local prescribing information before making any prescribing decisions.  THE INFORMATION CONTAINED ON THIS WEBSITE IS NOT INTENDED TO PROVIDE OR REPLACE MEDICAL ADVICE. VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD. HEREBY PROHIBITS YOU FROM USING THE INFORMATION ON THIS WEBSITE FOR DIAGNOSING A HEALTH OR FITNESS PROBLEM OR DISEASE. 

Disclaimer and Warranties.

Vifor Fresenius Medical Care Renal Pharma Ltd. will use reasonable efforts to include accurate, complete and up-to-date information on this Website. Information and related materials are subject to change without notice. This Website, and all information and related materials it contains, are provided "as is." Vifor Fresenius Medical Care Renal Pharma Ltd. makes no representation or warranty whatsoever regarding the completeness, accuracy, "up-to-dateness", or adequacy of, or the suitability, functionality, availability, or operation of this Website or the information or materials it contains. By using this Website, you assume the risk that the information and materials on this Website may be incomplete, inaccurate, out of date, or may not meet your needs and requirements. Vifor Fresenius Medical Care Renal Pharma Ltd. does not warrant that access to the Website will be available at all times or that the Website or the server that makes it available are free of viruses or other harmful components. Vifor Fresenius Medical Care Renal Pharma Ltd. specifically disclaims all warranties, express or implied, including without limitation, the warranties or merchantability, fitness for a particular purpose, and non-infringement with respect to this Website and information, graphics and materials contained herein.

Limitation of liability.

All users agree that access to this Website is at their own risk, and that neither Vifor Fresenius Medical Care Renal Pharma Ltd. nor any party involved in creating or delivering this Website shall be liable in any manner whatsoever for damages of any kind, including without limitation, any special, direct or indirect, incidental, or consequential or punitive damages (even if Vifor Fresenius Medical Care Renal Pharma Ltd. has been advised of the possibility of such damages) arising out of access to, reliance on, or (inability to) use of the information contained on this Website, or any errors or omissions, misprints, out-of-date information, technical or pricing inaccuracies, typographical or other errors appearing on this Website or from any interruption or discontinuation of any or all of the functionalities of the Website. This limitation includes damages to, or for any viruses that may infect your computer equipment. You, and not Vifor Fresenius Medical Care Renal Pharma Ltd., assume the entire cost of all necessary servicing, repair or corrections to your hardware, software or information whether or not caused by any virus or harmful component.

Copyright/Restriction on Use of Information.

This Website is copyright protected. Except as otherwise indicated, all copyright in the information is owned by Vifor Fresenius Medical Care Renal Pharma Ltd.. All rights in the information are reserved. You may only access, download or use information from this Website, including but not limited to texts, images, audio and video material, for your non-commercial use and provided you do not amend, edit or modify any of the material or change or delete any copyright, trademark or other proprietary notices. With the exception of the foregoing limited authorization, no license to or right in the information contained in this Website, or any copyright of Vifor Fresenius Medical Care Renal Pharma Ltd. or of any other party is hereby granted or conferred upon you.

Trademarks/proprietary rights.

You should assume that all logos and trademarks appearing on this Website are trademarks either owned by or licensed to Vifor Pharma or any of its affiliated companies. [The Website may also contain or reference patents, proprietary information, technologies, products, processes or other proprietary rights of Vifor Fresenius Medical Care Renal Pharma Ltd. and/or other parties.] No license to or right in any such trademarks, logos, [patents, domain names, technologies, products, processes and other proprietary information or rights] of Vifor Fresenius Medical Care Renal Pharma Ltd. and/or other parties is hereby granted to or conferred upon you. 

Links to this Website.

No link to this Website may be included in any other website without the prior written consent of Vifor Fresenius Medical Care Renal Pharma Ltd. unless it only directs the web visitor to the home page of this Website, in a separate pop-up window, with the full Website domain name and an appropriate pop-up notification to the visitor that it is accessing a third-party website. Vifor Fresenius Medical Care Renal Pharma Ltd. does not have responsibility for, or control of, the contents, availability, operation or performance of other web sites from which this web site may be accessed.

Links to other websites.

This Website may contain links to other web sites. Vifor Fresenius Medical Care Renal Pharma Ltd. does not have responsibility for, or control of, the contents, availability, operation or performance of other web sites to which this Website may be linked. Vifor Fresenius Medical Care Renal Pharma Ltd. makes no representation regarding the content of any other web sites which you may access from this Website.

Revisions.

Vifor Fresenius Medical Care Renal Pharma Ltd. reserves the right to alter or delete material from this Website at any time. Vifor Fresenius Medical Care Renal Pharma Ltd. may, at any time, revise these terms and conditions of use by updating this posting. You are bound by any such revisions and should, therefore, periodically review these terms to review the then current Website terms of use.

If any provision herein is held to be unlawful, void, or for any reason unenforceable, then that provision shall be eliminated or limited to the minimum extent necessary and such elimination or limitation shall not affect the validity and enforceability of any remaining provisions.

Jurisdiction.

You expressly agree that the exclusive jurisdiction for any dispute with Vifor Fresenius Medical Care Renal Pharma Ltd.or in any way relating to your use of this Website, exclusively resides in the courts of Zurich, Switzerland and you further agree and expressly consent to the exercise of personal jurisdiction in the courts of Zurich, Switzerland in connection with any such dispute including any claim involving Vifor Fresenius Medical Care Renal Pharma Ltd. or its affiliates, subsidiaries, employees, contractors, officers, directors, telecommunication providers, and content providers. 

Submission of information to this Website.

The submission of any unsolicited information, such as questions, comments, or suggestions, to Vifor Fresenius Medical Care Renal Pharma Ltd. through this Website shall NOT be considered confidential. Vifor Fresenius Medical Care Renal Pharma Ltd. shall have no obligation to you of any kind with respect to such information. By submitting any information to Vifor Fresenius Medical Care Renal Pharma Ltd., you understand that Vifor Fresenius Medical Care Renal Pharma Ltd. shall be free to reproduce, use, disclose, display, exhibit, transmit, perform, create derivative works, and distribute the information to others without limitation, and to authorise others to do the same. In addition, Vifor Fresenius Medical Care Renal Pharma Ltd. shall be free to use any ideas, concepts, know-how or techniques contained in such information for any purpose whatsoever, including but not limited to, developing, manufacturing and marketing products and other items incorporating such ideas, concepts, know-how or techniques.

As a HCP, you expressly agree that you will not submit any information that would directly identify a patient or any information for which you do not have all necessary consents or authorizations to disclose.

Cookies.

Please see Vifor Fresenius Medical Care Renal Pharma Ltd. Cookie Policy https://veltassa.com/global/cookie-settings for details.

Privacy.

Please see Vifor Fresenius Medical Care Renal Pharma Ltd Privacy Policy https://veltassa.com/global/privacy for details.

Questions and Comments.

Thank you for visiting the Website. We value your interest and ideas. If you have any comments or concerns regarding the use of the Website, including reports of non-functioning links, please contact us via the contact form on this Website. 

Passwords and Access Control.

This Website may require you to register or obtain a password before you are granted access to the content or certain services are made available to you on this Website. You are responsible for maintaining confidentiality of your sign-in details and password, as well as any use of thereof.

Date of last revision: 18.02.2021

Contact a Vifor medical representative

To learn more about hyperkalaemia management with Veltassa®, please contact us.

Contact us
logo

Address

Vifor Pharma Nordiska AB
Gustav III:s Boulevard 46,
169 73 Solna,
Sweden

Stay in touch

Keep up to date on social media or
Contact us with any other Information

Phone: +46 8 558 066 00
info.nordic@viforpharma.com

Sign up for alerts

Be notified of any news, reports or
updates straight to your email address

 Sign up and get the latest news

Footer

  • What is Hyperkalaemia?
    • K+ Homeostasis is critical
    • What causes hyperkalaemia?
    • HK is a serious medical condition
    • CKD and HF patients are at Risk of HK
  • HK Challenge in CKD
    • RAASI therapy is vital
    • HK Risk is exacerbated by RAASI
    • HK leads to suboptimal RAASI use
    • Current treatment options are limited
  • HK Challenge in HF
    • RAASI therapy is vital
    • HK Risk is exacerbated by RAASI
    • HK leads to suboptimal RAASI use
    • Current treatment options are limited
  • About Veltassa
    • What is Veltassa
    • Mechanism of action of Veltassa
    • Easy to use
  • Clinical Experience
    • Reliable K+ Control
    • RAASI enablement
    • Favourable safety and tolerability
    • Clinical programme
  • Resources
    • For you
    • For your patients

 Detta läkemedel är föremål för utökad övervakning.
Veltassa (patiromer), 8,4 g, 16,8 g och 25,2 g pulver till oral suspension, Rx, (F), Farmakoterapeutisk grupp: V03AE09, läkemedel för behandling av hyperkalemi och hyperfostatemi. Indikation: Behandling av hyperkalemi hos vuxna. Kontraindikation: Överkänslighet mot den aktiva substansen eller mot något hjälpämne. Varning och försiktighet: Veltassa ska inte användas som ersättning för akut behandling av livshotande hyperkalemi. Serummagnesium bör övervakas under minst 1 månad efter påbörjad behandling och magnesiumkomplettering övervägas hos patienter som utvecklar låga nivåer av serummagnesium. Nyttan och riskerna med administrering av Veltassa bör utvärderas noga hos patienter med rådande eller tidigare allvarliga gastrointestinala besvär före och under behandling, samt hos patienter med risk för hyperkalcemi.

Serumkalium bör övervakas när det är kliniskt indikerat, och efter att Veltassa-dosen har titrerats. Patienter bör instrueras att inte avbryta behandlingen utan att först rådgöra med läkare. Patienter med fruktosintolerans bör inte ta detta läkemedel. Förmån: Subventioneras endast för patienter med kronisk njursjukdom (CKD) i stadierna 3 till 5, med eller utan kronisk hjärtsvikt, för vilka behandling med Resonium inte är lämplig samt för patienter med kronisk hjärtsvikt utan samtidig kronisk njursjukdom.Baserad på produktresumé från 2020-10-15. För fullständig förskrivarinformation och priser se www.fass.se.
Vifor Pharma Nordiska AB www.viforpharma.se, info.nordic@viforpharma.com

Terms of use Privacy policy Cookie policy Prescribing information COOKIE SETTINGS
SE-PAT-2100008 | Date of preparation: November 2021